Average Insider

Where insiders trade, we follow

$YDES
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.
Healthcare
Sector
Biotechnology
Industry
J. Douglas Ramsey Jr.
CEO
4
Employees
$3.90
Current Price
$863.18M
Market Cap
52W Low$1.70
Current$3.909.4% above low, 90.6% below high
52W High$25.00

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys11$12,183.003,100All Buys
Sells00--
2 weeksBuys12$79,630.2621,478All Buys
Sells00--
1 monthBuys12$79,630.2621,478All Buys
Sells00--
2 monthsBuys12$79,630.2621,478All Buys
Sells00--
3 monthsBuys12$79,630.2621,478All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Sep 9, 2026
Shen Ethan PhD
Director
Purchase3,100$3.93$12,183.00View Details
Sep 4, 2026
Shen Ethan PhD
Director
Purchase18,378$3.67$67,447.26View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No past earnings data available
Version: v26.7.3